prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, RUN DATE: FAGE 1. RUN TIME: SPECIMEN INTERNAL INQUIRY. RUN USFR: FOR INTERNAL USE ONLY. NOT PART OF THE MEDICAL RECORD. LOC: U #. AGE/SX: ROOM: REG DR: BED: DIS: TLOC: SPEC #: RECV: REQ # : SPEC: TYPE: ASSN TO: PT AGE AT RECV: ENTERED : ENT BY: OTHR DR: DEPT: RECV BY: LAST RPTD: WKLD FN: LAST ACT: BAR CD#: SLIDES: SP IHC STAIN/17. ORD SITE: TRANSIT SITE: RCV SITE: PERFORM SITE: AT SITE: RPT AUDIT: C11. STATUS HX: ENT. GRSS. DIAG. SOUT. CODES: T04000 - BREAST. T04000 M80001 - BREASTINEOPLASM, UNCER. T04000 I M80003 - BREASTINEOPLASM, MALIG. T04000 M85003 - BREASTIINFILTRATING DU. TC4000 - LYMPH NODE. TC4000 M33150 - LYMPH NODE|COMEDO. TC4000. M55201 - LYMPH NODE|FATTY INFILTRAT. TC4000 M67100 - LYMPH NODE PLEOMORPHISM. TC4000 M80001 - LYMPH NODE I NEOPLASM, UNCER. TC4000 M85003 - LYMPH NODE I INFILTRATING DU. TE0120 M80001 - CHROMATIN, NOS INEOPLASM, UNCER. RUN DATE: SPECIMEN INTERNAL INQUIRY. RUN TIME: RUN USER: FOR INTERNAL USE ONLY. NOT PART OF THE MEDICAL RECORD. SPEC #: ICD CODES: 706.1 -. PROCEDURES: SP IHC STAIN. TISSUES: A. BREAST - LEFT SENTINEL NODE 1. B. BREAST - SENTINEL NODE #2 COUNT#. C. D. BREAST - LEFT BREAST TISSUE ORIENTED WITH SHORT SUPERIOR LONG LATERAL. BREAST - SENTINEL NODE #3 COUNT. PRE-OP DX: LEFT BREAST CANCER. PROCEDURE: LEFT BREAST MASTECTOMY AND RECONSTRUCTION. SPECIMEN A IS LABELED SENTINEL LYMPH NODE AND CONSISTS OF A 4.0 x 2.5 x 2.3 CM OVAL,. PINK-TAN LYMPH NODE. THE CAPSULE IS INTACT. CUT SECTION REVEALS 80% OF THE LYMPH NODE. REPLACED BY FAT. THE RIM IS LIGHT BROWN-TAN WITH NO GROSS EVIDENCE OF TUMOR. MOST OF THE. NODE IS SUBMITTED FOR FROZEN SECTION. SCRAPE PREP DONE. SPECIMEN B IS LABELED SENTINEL LYMPH NODE #2 AND CONSISTS OF AN OVAL PIECE OF FIBROFATTY FIRM,. TISSUE MEASURING 2.0 CM IN GREATEST DIMENSION. WITHIN THE FAT, THERE ARE TWO OVAL, FOR. PINK-TAN LYMPH NODES, EACH MEASURING 8.0 MM IN GREATEST DIMENSION. SUBMITTED IN TOTO. FROZEN SECTION. C IS LABELED SENTINEL LYMPH NODE #3 AND CONSISTS OF A 2.0 CM PIECE OF PINK-YELLOW,. SPECIMEN FIBROFATTY TISSUE. WITHIN THE FAT IS A 1.0 CM, YELLOW-TAN, FATTY-APPEARING LYMPH NODE. LYMPH NODE IS SUBMITTED IN TOTO FOR FROZEN SECTION. SPECIMEN D IS LABELED LEFT BREAST TISSUE AND CONSISTS OF 1370 GRAMS LEFT MASTECTOMY WITHOUT CM. AXILLARY DISSECTION (24 x 23 x 6.6 CM) WITH BROWN-TAN SKIN (18 x 11.5 CM), AREOLA ON (4.0 THE. DIAMETER), NIPPLE (1.0 x 0.5 CM) . BOTH AREOLA AND NIPPLE ARE UNREMARKABLE. SURFACE IN OF THE SKIN, THERE ARE TWO BROWN-TAN SLIGHTLY ELEVATED, ROUND, WELL-CIRCUMSCRIBED. LESIONS LOCATED AT UPPER OUTER QUADRANT (0.2 CM IN GREATEST DIMENSION) AND UPPER INNER. QUADRANT (0.4 CM IN GREATEST DIMENSION) THE DEEP SURGICAL RESECTION MARGIN IS INKED. RUN DATE: RUN TIME: PTH SPECIMEN INTERNAL INQUIRY. RUN USER: FOR INTERNAL USE ONLY. NOT PART OF THE MEDICAL RECORD. SPEC #: BLACK. CROSS SECTIONS REVEAL A ILL-DEFINED, WHITE-TAN, FIRM, GRITTY MASS (3.5 x 3.5 X. 2.0. CM), MULTIFOCAL WITH CALCIFICATIONS IN THE UPPER OUTER QUADRANT, LOCATED AT 5.5 CM OF. THE. DEEP RESECTION MARGIN, LESS THAN 0.1 CM FROM THE SUPERIOR RESECTION MARGIN, 6.0 CM FROM THE. LATERAL MARGIN, 11 CM FROM THE MEDIAL RESECTION MARGIN AND 7.0 CM FROM THE INFERIOR. RESECTION MARGIN. STROMAL FAT RATIO IS 20:80. THE SPECIMEN IS SUBMITTED AS FOLLOWS: 1 - SUPERIOR RESECTION MARGIN. 2 - INFERIOR RESECTION MARGIN. 3 - MEDIAL RESECTION MARGIN. 4 - LATERAL RESECTION MARGIN. 5 - ANTERIOR RESECTION MARGIN (NIPPLE). 6 - DEEP RESECTION MARGIN. 7-8 - REPRESENTATIVE SECTIONS FROM THE TUMOR. 9-10 - COMPOSITE SECTION FROM THE TUMOR. 11-12 - INTERVENING PARENCHYMA. 13-20 - REPRESENTATIVE SECTIONS FROM MULTIFOCAL TUMORAL LESION. 21 - REPRESENTATIVE SECTIONS FROM THE LESION DESCRIBED. ? M.D. A. SENTINEL LYMPH NODE. LARGE LYMPH NODE WITH EXTENSIVE FATTY INFILTRATION, NGATIVE FOR TUMOR. - SENTINEL LYMPH NODE IS NEGATIVE FOR MICROMETASTASIS BY IHC. B. SENTINEL NODE. - NEGATIVE FOR TUMOR. - SENTINEL LYMPH NODE IS NEGATIVE FOR MICROMETASTASIS BY IHC. C. SENTINEL NODE #3 COUNT. - NEGATIVE FOR TUMOR. LYMPH NODE IS NEGATIVE FOR MICROMETASTASIS BY IHC. D. BREAST, LEFT}. - MULTIFOCAL HIGH-GRADE INFILTRATING DUCTAL CARCINOMA. - MARGINS ARE NEGATIVE FOR TUMOR. - SEE BREAST CANCER STAGING BELOW. TUMOR IS STRONLY POSITIVE FOR ER/PR AND HER-2 NEU (3+ TO 4+). CONSIDER HER-2 BY FISH TEST TO CONFIRM AMPLIFICATION. CASE SUMMARY. SPECIMEN TYPE: MASTECTOMY: LYMPH NODE: SENTINEL LYMPH NODE (S) ONLY. LATERALITY: LEFT. TUMOR SITE: UPPER OUTER QUADRANT. SIZE OF INVASE COMPONENT: GREATEST DIMENSION: 3.5 CM. RUN DATE: PTH SPECIMEN INTERNAL INQUIRY. RUN TIME: RUN USER: FOR INTERNAL USE ONLY. NOT PART OF THE MEDICAL RECORD. SPEC #: HISTOLOGIC TYPE: TWO (2) DUCTAL CARCINOMA IN SITU HIGH GRADE COMEDO TYPE. ONE (1) INVASIVE DUCTAL CARCINOMA. TUBULE PLEOMORPHISM: MARKED VARIATION INSIZE, NUCLEOLI, CHROMATIN CLUMPING, 10 HPF ETC (SCORE=3) (SCORE=3). FORMATION: MINIMAL LESS THAN 10% (SCORE=3). NUCLEAR MITOTIC COUNT (FOR THOSE USING NOTTINGHAM SYSTEM) : 10 TO 20 MITOSES PER. TOTAL TUMOR (pT) : pT2: TUMOR MORE THAN 2.0 CM BUT NOT MORE THAN 5.0 HISTOLOGICALLY, IN GREATEST. NOTTINGHAM SCORE: GRADE III:8-9 POINTS. DIMENSION. PRIMARY LYMPH NODES (pN) : pNO (i-) : NO REGIONAL LYMPH NODE METASTASIS AND. NEGATIVE REGIONAL MORPHOLOGIC (ANY MORPHOLOGIC TECHNIQUE, INCLUDING HEMATOXYLIN-EOSIN. IMMUNOHISTOCHEMISTRY) FINDINGS FOR ITCs. SPECIFY : NUMBER EXAMINED: 4. NUMBER INVOLVED: o. DISTANT METASTASIS (pM) : pMX: CANNOT BE ASSESSED. MARGINS: MARGINS UNIVOLVED BY INVASIVE CARCINOMA. DISTANT FROM CLOSEST MARGIN: 1 MM, SUPERIOR LATERAL. VENOUS: INDETERMINATE. MICROCALCIFICATIONS: PRESENT DCIS. M.D. A. SENTINEL LYMPH NODE: LARGE LYMPH NODE WITH EXTENSIVE FATTY INFILTRATION, NEGATIVE FOR. TUMOR. B. SENTINEL LYMPH NODE #2: LYMPH NODE NEGATIVE FOR TUMOR. C. SENTINEL LYMPH NODE #3: LYMPH NODE NEGATIVE FOR TUMOR. M.D. > by. M.D. ESIG ADD/PARC SEC ACTION ENTERED BY DATE. TIME. SIGN OUT AUDIT. TYPE. NEW. M.D.

expanded version (tokens=2543) : 
 From the breast pathology report, the following information can be extracted:

1. Histological classification: The tumor is a high-grade infiltrating ductal carcinoma.
2. Subtype: Luminal B
3. Description of necrosis: There is no mention of necrosis.
4. Tumor-infiltrating lymphocytes: There is no mention of lymphocytes infiltrating the tumor.
5. Histological grade: Grade III (score=8-9 points).
6. Nuclear grade: Marked variation in size and nuclear characteristics (score=3).
7. Lymphovascular invasion: There is no mention of lymphovascular invasion.
8. Calcification: DCIS with microcalcifications is present.
9. Receptor status: The tumor is strongly ER/PR positive and HER-2 neu (3+ to 4+). HER-2 amplification is recommended to be confirmed by FISH test.
10. IHC and ancillary testing results: 
    A. Sentinel lymph node - negative for tumor.
    B. Sentinel lymph node #2 - negative for tumor.
    C. Sentinel lymph node #3 - negative for tumor.
    D. Margins are negative for tumor.

The report also mentions the size and location of the tumor, the presence of DCIS, and details about the surgical procedure and specimens.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2708) : 
 The breast pathology report indicates a high-grade infiltrating ductal carcinoma with microcalcifications in DCIS. The tumor is strongly ER/PR positive and HER-2 neu (3+ to 4+), with the recommendation of HER-2 amplification by FISH test. Sentinel lymph nodes are negative for tumor, margins are uninvolved, and there is no lymphovascular invasion nor tumor-infiltrating lymphocytes mentioned. The surgical procedure involved a left breast mastectomy and reconstruction, and specimens were obtained from multiple areas including the sentinel nodes and the tumor for further testing.

